The efficacy of tourniquet assisted total knee arthroplasty on patient-reported and performance-based physical function: a randomized controlled trial protocol

BMC Musculoskeletal Disorders

Carsten Jensen¹  Søren Overgaard¹  Claus Emmeluth¹  Anders Holsgaard-Larsen¹  Rasmus Lohmann-Jensen¹ 

[1] Institute of Clinical Research, University of Southern Denmark, Odense C, Denmark

关键词: Physical function;    Performance-based;    Patient-reported;    Total knee arthroplasty;    Tourniquet;   

Others  :  1127774
DOI  :  10.1186/1471-2474-15-110

 received in 2013-07-05, accepted in 2014-03-20,  发布年份 2014

【 摘 要 】

Background

Surgical treatment of osteoarthritis with total knee arthroplasty (TKA) usually takes place in a complete bloodless field using a tourniquet. However, doing the surgery without a tourniquet may reduce muscle damage, post-surgery pain and led to improved functional rehabilitation and mobilization.

Methods/Design

A prospective, blinded, parallel-group, controlled superiority trial, with balanced randomization [1:1]. Patients aged 50 or older eligible for primary TKA for osteoarthritis will be consecutively recruited from Department of Orthopedic Surgery and Traumatology, Odense University Hospital, Denmark. A total of 80 patients will be randomly allocated to TKA with or without tourniquet application providing 40 patients for each of the two treatment arms. The tourniquet assisted TKA group will have an automatic, micro-processor-based pneumatic tourniquet inflated around the thigh during surgery. The non-tourniquet assisted TKA group will have surgery performed without application of a tourniquet. The primary aim is to compare tourniquet assisted to non-tourniquet assisted TKA on patient-reported physical function (KOOS-ADL). The secondary aim is to compare post-surgery pain, function in sports and recreation, quality of life, and performance-based physical function. The explorative outcomes include; use of pain medication, single-fiber muscle damage, and changes in mechanical muscle function. The primary endpoint will be at 3-months following surgical treatment, and the time-point for analysis of the primary outcome. However, follow-up will continue up to 1 year, and provide medium-term results. The treatment effect (difference in KOOS-ADL) will be analyzed using a random effects regression model, crude and adjusted results will be reported, if needed. Analyses will be based on the intention-to-treat (ITT). Subsequent per-protocol analysis may be necessary in the event of a substantial number of patients (> 15%) being lost during follow-up. The number needed to treat (NNT) for a positive effect of treatment (>10 points on KOOS-ADL) will be reported.

Discussion

This is the first randomized clinical trial comparing the efficacy of tourniquet assisted TKA on patient-reported physical function supported by a range of performance-based secondary outcome measures. As such it will provide high quality evidence that may help determine whether tourniquet should be used in future TKA procedures in patients with osteoarthritis of the knee.

Trial registration

ClinicalTrialsNCT01891266.

【 授权许可】

   
2014 Lohmann-Jensen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Brooks PM: Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol 2002, 14:573-577.
• [2]Izquierdo M, Aguado X, Gonzalez R, Lopez JL, Hakkinen K: Maximal and explosive force production capacity and balance performance in men of different ages. Eur J Appl Physiol Occup Physiol 1999, 79:260-267.
• [3]Salaffi F, Carotti M, Stancati A, Grassi W: Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res 2005, 17:255-263.
• [4]Buckwalter JA, Martin JA: Osteoarthritis. Adv Drug Deliv Rev 2006, 58:150-167.
• [5]Lapsley HM, March LM, Tribe KL, Cross MJ, Brooks PM: Living with osteoarthritis: patient expenditures, health status, and social impact. Arthritis Rheum 2001, 45:301-306.
• [6]Leigh JP, Seavey W, Leistikow B: Estimating the costs of job related arthritis. J Rheumatol 2001, 28:1647-1654.
• [7]Abdel-Salam A, Eyres KS: Effects of tourniquet during total knee arthroplasty. A prospective randomised study. J Bone Joint Surg (Br) 1995, 77:250-253.
• [8]Fukuda A, Hasegawa M, Kato K, Shi D, Sudo A, Uchida A: Effect of tourniquet application on deep vein thrombosis after total knee arthroplasty. Arch Orthop Trauma Surg 2007, 127:671-675.
• [9]Smith TO, Hing CB: A meta-analysis of tourniquet assisted arthroscopic knee surgery. Knee 2009, 16:317-321.
• [10]Tetro AM, Rudan JF: The effects of a pneumatic tourniquet on blood loss in total knee arthroplasty. Can J Surg 2001, 44:33-38.
• [11]Aglietti P, Baldini A, Vena LM, Abbate R, Fedi S, Falciani M: Effect of tourniquet use on activation of coagulation in total knee replacement. Clin Orthop Relat Res 2000, Feb:169-177.
• [12]Johnson DS, Stewart H, Hirst P, Harper NJ: Is tourniquet use necessary for knee arthroscopy? Arthroscopy 2000, 16:648-651.
• [13]Wakankar HM, Nicholl JE, Koka R, D’Arcy JC: The tourniquet in total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg (Br) 1999, 81:30-33.
• [14]Daniel DM, Lumkong G, Stone ML, Pedowitz RA: Effects of tourniquet use in anterior cruciate ligament reconstruction. Arthroscopy 1995, 11:307-311.
• [15]Smith TO, Hing CB: Is a tourniquet beneficial in total knee replacement surgery? A meta-analysis and systematic review. Knee 2010, 17:141-147.
• [16]Irving GA, Noakes TD: The protective role of local hypothermia in tourniquet-induced ischaemia of muscle. J Bone Joint Surg (Br) 1985, 67:297-301.
• [17]Newman RJ: Metabolic effects of tourniquet ischaemia studied by nuclear magnetic resonance spectroscopy. J Bone Joint Surg (Br) 1984, 66:434-440.
• [18]Olivecrona C, Blomfeldt R, Ponzer S, Stanford BR, Nilsson BY: Tourniquet cuff pressure and nerve injury in knee arthroplasty in a bloodless field: a neurophysiological study. Acta Orthop 2013, 84:159-164.
• [19]Sapega AA, Heppenstall RB, Chance B, Park YS, Sokolow D: Optimizing tourniquet application and release times in extremity surgery. A biochemical and ultrastructural study. J Bone Joint Surg Am 1985, 67:303-314.
• [20]Tai TW, Lin CJ, Jou IM, Chang CW, Lai KA, Yang CY: Tourniquet use in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2011, 19:1121-1130.
• [21]Nishiguchi M, Takamura N, Abe Y, Kono M, Shindo H, Aoyagi K: Pilot study on the use of tourniquet: a risk factor for pulmonary thromboembolism after total knee arthroplasty? Thromb Res 2005, 115:271-276.
• [22]McGrath BJ, Hsia J, Epstein B: Massive pulmonary embolism following tourniquet deflation. Anesthesiology 1991, 74:618-620.
• [23]Gielen M: Cardiac arrest after tourniquet release. Can J Anaesth 1991, 38:541.
• [24]Molt M, Harsten A, Toksvig-Larsen S: The effect of tourniquet use on fixation quality in cemented total knee arthroplasty a prospective randomized clinical controlled RSA trial. Knee 2013. Oct 24. doi: 10.1016/j.knee.2013.10.008. [Epub ahead of print]
• [25]Ledin H, Aspenberg P, Good L: Tourniquet use in total knee replacement does not improve fixation, but appears to reduce final range of motion. Acta Orthop 2012, 83:499-503.
• [26]Klenerman L: Is a tourniquet really necessary for knee replacement? J Bone Joint Surg (Br) 1995, 77:174-175.
• [27]Silver R, de la Garza J, Rang M, Koreska J: Limb swelling after release of a tourniquet. Clin Orthop Relat Res 1986, Maj:86-89.
• [28]Tibrewal SB: The pneumatic tourniquet in arthroscopic surgery of the knee. Int Orthop 2001, 24:347-349.
• [29]Saunders KC, Louis DL, Weingarden SI, Waylonis GW: Effect of tourniquet time on postoperative quadriceps function. Clin Orthop Relat Res 1979, Sep:194-199.
• [30]Jorgensen HR: Myoglobin release after tourniquet ischemia. Acta Orthop Scand 1987, 58:554-556.
• [31]Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG: CONSORT, explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010, 2010(63):e1-e37.
• [32]Schulz KF, Altman DG, Moher D: CONSORT, statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010, 2010(63):834-840.
• [33]Ahlback S: Osteoarthrosis of the knee. A radiographic investigation. Acta Radiol Diagn 1968, suppl. 277(7):72.
• [34]Schulz KF, Grimes DA: Multiplicity in randomised trials I: endpoints and treatments. Lancet 2005, 365:1591-1595.
• [35]Knee Disability and Osteoarthritis Outcome Score (KOOS) [http://www.koos.nu webcite]
• [36]Roos EM, Lohmander LS: The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes 2003, 1:64. BioMed Central Full Text
• [37]Roos EM, Roos HP, Ekdahl C, Lohmander LS: Knee injury and Osteoarthritis Outcome Score (KOOS)–validation of a Swedish version. Scand J Med Sci Sports 1998, 8:439-448.
• [38]Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HC: The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010, 19:539-549.
• [39]Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M: Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 1997, 24:799-802.
• [40]Poulsen E, Christensen HW, Penny JO, Overgaard S, Vach W, Hartvigsen J: Reproducibility of range of motion and muscle strength measurements in patients with hip osteoarthritis - an inter-rater study. BMC Musculoskelet Disord 2012, 13:242. BioMed Central Full Text
• [41]Gogia PP, Braatz JH, Rose SJ, Norton BJ: Reliability and validity of goniometric measurements at the knee. Phys Ther 1987, 67:192-195.
• [42]Jones CJ, Rikli RE, Beam WC: A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport 1999, 70:113-119.
• [43]Bohannon RW: Sit-to-stand test for measuring performance of lower extremity muscles. Percept Mot Skills 1995, 80:163-166.
• [44]Villadsen A, Roos EM, Overgaard S, Holsgaard-Larsen A: Agreement and reliability of functional performance and muscle power in patients with advanced osteoarthritis of the hip or knee. Am J Phys Med Rehabil 2012, 91:401-410.
• [45]Dobson F, Hinman RS, Roos EM, Abbott JH, Stratford P, Davis AM, Buchbinder R, Snyder-Mackler L, Henrotin Y, Thumboo J, Hansen P, Bennell KL: OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis. Osteoarthritis Cartilage 2013, 21:1042-1052.
• [46]Marks R: Reliability and validity of self-paced walking time measures for knee osteoarthritis. Arthritis Care Res 1994, 7:50-53.
• [47]Podsiadlo D, Richardson S: The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991, 39:142-148.
• [48]Yeung TS, Wessel J, Stratford PW, MacDermid JC: The timed up and go test for use on an inpatient orthopaedic rehabilitation ward. J Orthop Sports Phys Ther 2008, 38:410-417.
• [49]Rikli RE, Jones CJ: Development and validation of criterion-referenced clinically relevant fitness standards for maintaining physical independence in later years. Gerontologist 2013, 53:255-267.
• [50]Boeckstyns ME, Backer M: Reliability and validity of the evaluation of pain in patients with total knee replacement. Pain 1989, 38:29-33.
• [51]Jensen C, Aagaard P, Overgaard S: Recovery in mechanical muscle strength following resurfacing vs standard total hip arthroplasty - a randomised clinical trial. Osteoarthritis Cartilage 2011, 19:1108-1116.
• [52]Aagaard P, Simonsen EB, Andersen JL, Magnusson P, Dyhre-Poulsen P: Increased rate of force development and neural drive of human skeletal muscle following resistance training. J Appl Physiol 2002, 93:1318-1326.
• [53]Mizner RL, Snyder-Mackler L: Altered loading during walking and sit-to-stand is affected by quadriceps weakness after total knee arthroplasty. J Orthop Res 2005, 23:1083-1090.
• [54]Fransen M, Crosbie J, Edmonds J: Isometric muscle force measurement for clinicians treating patients with osteoarthritis of the knee. Arthritis Rheum 2003, 49:29-35.
• [55]Robertson S, Frost H, Doll H, O’Connor JJ: Leg extensor power and quadriceps strength: an assessment of repeatability in patients with osteoarthritic knees. Clin Rehabil 1998, 12:120-126.
• [56]Bassey EJ, Short AH: A new method for measuring power output in a single leg extension: feasibility, reliability and validity. Eur J Appl Physiol Occup Physiol 1990, 60:385-390.
• [57]Maffiuletti NA, Bizzini M, Widler K, Munzinger U: Asymmetry in quadriceps rate of force development as a functional outcome measure in TKA. Clin Orthop Relat Res 2010, 468:191-198.
• [58]Pijnappels M, Bobbert MF, van Dieen JH: Control of support limb muscles in recovery after tripping in young and older subjects. Exp Brain Res 2005, 160:326-333.
• [59]Surface ElectroMyoGraphy for the Non-Invasive Assessment of Muscles (SENIAM) [http://www.seniam.org webcite]
• [60]Burden A: How should we normalize electromyograms obtained from healthy participants? What we have learned from over 25 years of research. J Electromyogr Kinesiol 2010, 20:1023-1035.
• [61]Bremander AB, Dahl LL, Roos EM: Validity and reliability of functional performance tests in meniscectomized patients with or without knee osteoarthritis. Scand J Med Sci Sports 2007, 17:120-127.
• [62]Rabe-Hesketh S, Skrondal A: Multilevel and Longitudinal Modeling Using Stata. College Station, Texas: Stata Press; 2008.
• [63]Sainani KL: Making sense of intention-to-treat. PM R 2010, 2:209-213.
• [64]Jordan KP, Wilkie R, Muller S, Myers H, Nicholls E: Measurement of change in function and disability in osteoarthritis: current approaches and future challenges. Curr Opin Rheumatol 2009, 21:525-530.
• [65]Wright AA, Hegedus EJ, Baxter GD, Abbott JH: Measurement of function in hip osteoarthritis: developing a standardized approach for physical performance measures. Physiother Theory Pract 2011, 27:253-262.
• [66]Stratford PW, Kennedy DM: Performance measures were necessary to obtain a complete picture of osteoarthritic patients. J Clin Epidemiol 2006, 59:160-167.
• [67]Terwee CB, Mokkink LB, Steultjens MP, Dekker J: Performance-based methods for measuring the physical function of patients with osteoarthritis of the hip or knee: a systematic review of measurement properties. Rheumatology (Oxford) 2006, 45:890-902.
• [68]International Classification of Functioning, Disability and Health (ICF) [http://www.who.int/classifications/icf/en webcite]
• [69]Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW: Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 15:1833-1840.
• [70]Rasch A, Bystrom AH, Dalen N, Berg HE: Reduced muscle radiological density, cross-sectional area, and strength of major hip and knee muscles in 22 patients with hip osteoarthritis. Acta Orthop 2007, 78:505-510.
• [71]Krebs DE: Isokinetic, electrophysiologic, and clinical function relationships following tourniquet-aided knee arthrotomy. Phys Ther 1989, 69:803-815.
• [72]Finsen V, Kasseth AM: Tourniquets in forefoot surgery: less pain when placed at the ankle. J Bone Joint Surg (Br) 1997, 79:99-101.